← Leaderboards
Fred Douglass Finkelman
University Of Cincinnati
$18,476,629
Attributed
$19,798,215
Total exposure
18
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$19,798,215 · 17
VA$0 · 1
By mechanism
R01$17,131,139 · 12
P01$1,622,618 · 1
R21$1,044,458 · 3
I01$0 · 1
P30$0 · 1
Top collaborators
- Marat Khodoun5 shared
Most similar at University Of Cincinnati
Same institution · by research overlap
- Marat Khodoun$1,321,587
Others in their field
Top investigators on “Prevent”
- Lawrence Corey · Fred Hutchinson Cancer Center$609,181,782
- Jeffrey P Krischer · University Of South Florida$605,511,231
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$530,065,238
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$499,311,118
- David Heimbrook · Leidos Biomedical Research, Inc.$496,394,926
Research focus
PreventMediatingMouse ModelIn VivoMonoclonal AntibodiesAntigensCytokineAffinityCellsSignal TransductionDoseCell TypeReceptorBinding (Molecular Function)AsthmaResponseAllergensAntibodiesProductionResearch StudyCytokine ReceptorsIn VitroImmunoglobulin GAllergic
Grant awards (67)
Rapid, safe suppression of IgE-mediated disease with monovalent anti-ceRIa mAb$541,238
R01 · FY2023 · AI · contact PI
Rapid, safe suppression of IgE-mediated disease with monovalent anti-ceRIa mAb$566,118
R01 · FY2022 · AI · contact PI
Rapid, safe suppression of IgE-mediated disease with monovalent anti-ceRIa mAb$566,118
R01 · FY2021 · AI · contact PI
Wimpy antibody isotypes protect against antibody-mediated disease$365,342
R01 · FY2021 · AI · contact PI
Rapid, safe suppression of IgE-mediated disease with monovalent anti-ceRIa mAb$585,704
R01 · FY2020 · AI · contact PI
Wimpy antibody isotypes protect against antibody-mediated disease$365,342
R01 · FY2020 · AI · contact PI
Rapid, safe suppression of IgE-mediated disease with monovalent anti-ceRIa mAb$383,995
R01 · FY2019 · AI · contact PI
Wimpy antibody isotypes protect against antibody-mediated disease$365,342
R01 · FY2019 · AI · contact PI
Wimpy antibody isotypes protect against antibody-mediated disease$365,342
R01 · FY2018 · AI · contact PI
Suppression of IgE-Mediated Disease by Polyclonal Rapid Desensitization$483,864
R01 · FY2017 · AI · contact PI
Wimpy antibody isotypes protect against antibody-mediated disease$371,842
R01 · FY2017 · AI · contact PI
Suppression of IgE-Mediated Disease by Polyclonal Rapid Desensitization$432,266
R01 · FY2016 · AI · contact PI
Suppression of IgE-Mediated Disease by Polyclonal Rapid Desensitization$331,764
R01 · FY2015 · AI · contact PI
Suppression of established IgE-mediated disease$0
I01 · FY2015 · VA · contact PI
Allergenicity resulting from functional mimicry of the TLR complex$376,324
R01 · FY2014 · AI · contact PI
Suppression of IgE-Mediated Disease by Polyclonal Rapid Desensitization$337,775
R01 · FY2014 · AI · contact PI
Suppression of established IgE-mediated disease$0
I01 · FY2014 · VA · contact PI
Allergenicity resulting from functional mimicry of the TLR complex$353,745
R01 · FY2013 · AI · contact PI
Human IgG-mediated Anaphylaxis$218,703
R21 · FY2013 · AI · contact PI
Suppression of established IgE-mediated disease$0
I01 · FY2013 · VA · contact PI
Regulation of CD8+ T Cell Homeostatis by IL-4$382,239
R01 · FY2012 · AI · contact PI
Allergenicity resulting from functional mimicry of the TLR complex$376,324
R01 · FY2012 · AI · contact PI
Human IgG-mediated Anaphylaxis$207,755
R21 · FY2012 · AI · contact PI
Suppression of established IgE-mediated disease$0
I01 · FY2012 · VA · contact PI
Regulation of CD8+ T Cell Homeostatis by IL-4$382,239
R01 · FY2011 · AI · contact PI
IgG Isotype Regulation of Antibody-Mediated Disorders$369,933
R01 · FY2011 · AI · contact PI
Direct IL-4 and IL-13 effects on pulmonary smooth muscle in allergic airway disea$476,818
R01 · FY2010 · HL · contact PI
Regulation of CD8+ T Cell Homeostatis by IL-4$386,100
R01 · FY2010 · AI · contact PI
IgG Isotype Regulation of Antibody-Mediated Disorders$373,670
R01 · FY2010 · AI · contact PI
Direct IL-4 and IL-13 effects on pulmonary smooth muscle in allergic airway disea$473,954
R01 · FY2009 · HL · contact PI
Regulation of CD8+ T Cell Homeostatis by IL-4$390,000
R01 · FY2009 · AI · contact PI
IgG Isotype Regulation of Antibody-Mediated Disorders$377,444
R01 · FY2009 · AI · contact PI
Identification Of Proteins Responsible For Peanut Allergenicity$234,000
R21 · FY2009 · AI · contact PI
Unique Effects of IL-13 in Asthma: Mechanistic Analysis$426,633
P01 · FY2008 · HL · contact PI
Regulation of CD8+ T Cell Homeostatis by IL-4$390,000
R01 · FY2008 · AI · contact PI
IgG Isotype Regulation of Antibody-Mediated Disorders$377,444
R01 · FY2008 · AI · contact PI
Identification Of Proteins Responsible For Peanut Allergenicity$195,000
R21 · FY2008 · AI · contact PI
IgG Isotype Regulation of Antibody-Mediated Disorders$426,832
R01 · FY2007 · AI · contact PI
Unique Effects of IL-13 in Asthma: Mechanistic Analysis$423,938
P01 · FY2007 · HL · contact PI
Cellular targets of IL-4 and IL-13 in worm expulsion$303,644
R01 · FY2007 · AI · contact PI
Role of Inflammatory Cytokines in the Allergic Response$258,142
R01 · FY2007 · AI · contact PI
Cellular targets of IL-4 and IL-13 in worm expulsion$357,458
R01 · FY2006 · AI · contact PI
Role of Inflammatory Cytokines in the Allergic Response$265,966
R01 · FY2006 · AI · contact PI
Unique Effects of IL-13 in Asthma: Mechanistic Analysis$264,628
P01 · FY2006 · HL · contact PI
Cellular targets of IL-4 and IL-13 in worm expulsion$295,500
R01 · FY2005 · AI
Role of Inflammatory Cytokines in the Allergic Response$272,484
R01 · FY2005 · AI
Unique Effects of IL-13 in Asthma: Mechanistic Analysis$257,418
P01 · FY2005 · HL
Cellular targets of IL-4 and IL-13 in worm expulsion$47,459
R01 · FY2005 · AI
Cellular targets of IL-4 and IL-13 in worm expulsion$295,500
R01 · FY2004 · AI
Role of Inflammatory Cytokines in the Allergic Response$273,710
R01 · FY2004 · AI
Unique Effects of IL-13 in Asthma: Mechanistic Analysis$250,001
P01 · FY2004 · HL
Cellular targets of IL-4 and IL-13 in worm expulsion$308,500
R01 · FY2003 · AI
CYTOKINE REGULATION OF A MOUSE MODEL OF ASTHMA$255,117
R01 · FY2003 · AI
IL4R AND IMMUNITY TO GI NEMATODE PARASITES$212,910
R01 · FY2003 · AI
Inflammatory Cytokines in the Allergic Response$141,750
R01 · FY2003 · AI
CYTOKINE REGULATION OF A MOUSE MODEL OF ASTHMA$235,368
R01 · FY2002 · AI
IL4R AND IMMUNITY TO GI NEMATODE PARASITES$206,709
R01 · FY2002 · AI
REGULATION OF IL4 PRODUCTION IN VIVO$189,121
R01 · FY2002 · AI
CORE--CYTOKINE QUANTITATION$0
P30 · FY2002 · AR
CYTOKINE REGULATION OF A MOUSE MODEL OF ASTHMA$242,393
R01 · FY2001 · AI
IL4R AND IMMUNITY TO GI NEMATODE PARASITES$200,688
R01 · FY2001 · AI
REGULATION OF IL4 PRODUCTION IN VIVO$183,614
R01 · FY2001 · AI
CORE--CYTOKINE QUANTITATION$0
P30 · FY2001 · AR
CYTOKINE REGULATION OF A MOUSE MODEL OF ASTHMA$236,879
R01 · FY2000 · AI
IL4R AND IMMUNITY TO GI NEMATODE PARASITES$194,843
R01 · FY2000 · AI
A SERUM ASSAY FOR IN VIVO CYTOKINE PRODUCTION$189,000
R21 · FY2000 · AI
REGULATION OF IL4 PRODUCTION IN VIVO$178,266
R01 · FY2000 · AI